Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185575 · ClinicalTrials.gov registry record · NA
Duloxetine for the Treatment of Dysthymia
A NA study of Depressive Disorder, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00185575 is a NA study of Depressive Disorder that has completed, run by Stanford University. The registered enrollment target is 24 participants, below the 331-participant average among 47 other Depressive Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00185575, a NA study of Depressive Disorder, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the hypothesis that duloxetine (Cymbalta), in doses of 60 or 120 mg/day, is an effective and tolerable treatment for adult outpatients suffering from dysthymia. Dysthymia is chronic, mild depression characterized by feeling sad or low more days than not for more than 2 years.
Conditions Studied
Interventions
- DRUG duloxetine
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-09 |
| Est. Completion | 2006-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185575
The ClinicalTrials.gov registry entry for NCT00185575 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 331-participant average among 47 other Depressive Disorder trials with a reported enrollment target (93% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which duloxetine is the first listed.
NCT00185575 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00185575 about?
NCT00185575 is a clinical study titled "Duloxetine for the Treatment of Dysthymia". The purpose of this study is to test the hypothesis that duloxetine (Cymbalta), in doses of 60 or 120 mg/day, is an effective and tolerable treatment for adult outpatients suffering from dysthymia. Dysthymia is chronic, mild depression characterized by feeling sad or low more days than not for more ...
What is the current status of trial NCT00185575?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2004-09. Estimated completion is 2006-04.
What conditions does trial NCT00185575 study?
This clinical trial studies the following conditions: Depressive Disorder.
What interventions are being tested in trial NCT00185575?
The interventions under investigation include: duloxetine (DRUG).
Who is sponsoring clinical trial NCT00185575?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00185575 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
-
Measurement-Based Care (MBC) Implementation, Effectiveness, and Mechanisms of Change
RECRUITING · NA
-
Research Evaluating Vagal Excitation AND Anatomical Links
RECRUITING · NA
-
Unified Protocol: Community Connections
RECRUITING · NA
-
Enhancing Brain And Mental Health Through Breathing Practice
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.